Results 81 to 90 of about 32,116 (179)

The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders

Future Pharmacology
Individuals suffering from diverse neuropsychiatric and neurodegenerative disorders often have comparable symptoms, which may underline the implication of shared hereditary influences and the same biological processes.
Simona Dedoni, Chiara Camoglio, Carlotta Siddi, Maria Scherma, Walter Fratta, Paola Fadda   +5 more
doaj   +1 more source

Decreased plasma gelsolin in the COVID-19-related acute respiratory distress syndrome

Türk Biyokimya Dergisi
The aim of this study was to evaluate the potential roles of plasma gelsolin (pGSN), transforming growth factor-beta1 (TGF-β1), and lysophosphatidic acid (LPA) as profibrotic and immune modulatory markers in patients with acute respiratory distress ...
Gunturk Inayet, Seydel Gonul Seyda, Yazici Cevat, Topaloglu Ulas Serkan, Eren Esma, Yuksel Recep Civan   +5 more
doaj   +1 more source

Lysophosphatidic acid

British Journal of Pharmacology, 2009
openaire   +3 more sources

The role of lysophosphatidic acid metabolism in castration-resistant prostate cancer progression. [PDF]

Front Oncol
Feng J, Liu J, He Y.
europepmc   +1 more source

[Lysophosphatidic acid: a "bioactive" phospholipid].

Medecine sciences : M/S, 2004
Lysophosphatidic acid (LPA) is a "bioactive" phospholipid able to generate growth factor-like activities in a wide variety of normal and malignant cell types. LPA is proposed to play an important role in normal physiological situations such as wound healing, vascular tone, vascular integrity, or reproduction.
openaire   +2 more sources

Temporal Lysophosphatidic Acid Supplementation Enhances Megakaryocyte Differentiation and Platelet Production From Human Hematopoietic Progenitors. [PDF]

Cell Biol Int
Jiamvoraphong N, Lorthongpanich C, Septham P, Klaihmon P, Kheolamai P, Laowtammathron C, Imsoonthornruksa S, Ketudat-Cairns M, Issaragrisil S.   +8 more
europepmc   +1 more source

Lysophosphatidic Acid Reduces Ischemic Brain Injury by Attenuating Vascular Permeability Through LPA4 Receptor Signaling. [PDF]

Transl Stroke Res
Yamada S, Takara K, Hosoe N, Shimizu A, Hayashi Y, Lynda L, Sonoda T, Kikuta K, Kidoya H.   +8 more
europepmc   +1 more source

Lysophosphatidic acid mediates skeletal muscle fibrosis in denervation via activation of YAP/TAZ. [PDF]

JCI Insight
Cruz-Soca M, Córdova-Casanova A, Faundez-Contreras J, Martínez NW, Vaccaro-Rivera F, Bazaes-Astorga S, Gutiérrez-Rojas C, Gallardo FS, Rebolledo DL, Court FA, Chun J, Vio CP, Matus S, Casar JC, Brandan E.   +14 more
europepmc   +1 more source

AGPAT3 Regulates Immune Microenvironment in Osteosarcoma via Lysophosphatidic Acid Metabolism. [PDF]

Oncol Res
Su S, Zeng Y, Chen J, Dong X.
europepmc   +1 more source

Lysophosphatidic acid: a promising biomarker for diagnosing sepsis and predicting in-hospital mortality. [PDF]

Front Immunol
Li X, Li T, Xuan P, Wang H, Yang J.
europepmc   +1 more source